(Q44601141)

4 December 2017

Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem (English)

1 reference

4 December 2017

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem (English)

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517194

15 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

15 March 2024

1 reference

4

David P. Nicolau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517194

15 March 2024

author name string

Joseph L. Kuti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517194

15 March 2024

Prachi K. Dandekar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517194

15 March 2024

Charles H. Nightingale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517194

15 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517194

15 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003257225

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003257225

15 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

The Journal of Clinical Pharmacology

15 March 2024

published in

1 reference

4 December 2017

43

1 reference

4 December 2017

10

1 reference

4 December 2017

1116-1123

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

4 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Continuous infusion versus intermittent administration of meropenem in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Meropenem clinical pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

The pharmacokinetics of meropenem in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257225

Economic benefit of a meropenem dosage strategy based on pharmacodynamic concepts.

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae

15 March 2024

8

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

The pharmacodynamics of beta-lactams

15 March 2024

12

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

Stability of meropenem in intravenous solutions

15 March 2024

15

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

Stability of meropenem in a portable infusion device in a cold pouch

15 March 2024

16

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.

15 March 2024

19

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances

15 March 2024

21

1 reference

https://api.crossref.org/works/10.1177/0091270003257225

15 March 2024

Identifiers

1 reference

4 December 2017

1 reference